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Summary The pre-surgical work-up of patients with medically refractory epilepsy
changes with the availability of new diagnostic procedures. New diagnostic investiga-
tions may also open up prospects for patients rejected in the past. A cohort of 71
Dutch patients rejected for epilepsy surgery 0.5—5 years earlier were approached to
evaluate their willingness to undergo novel techniques. 64 (90%) responded to a
questionnaire evaluating social and medical status, quality of life (QoL) and motiva-
tion to be reconsidered for epilepsy surgery. Four patients (6%) did not have seizures
during the last 6 months. 56 patients (88%) were highly motivated to undergo new
diagnostic procedures. Inability to localize the seizure focus had been the reason for
rejection in 70% of these. We conclude that most patients once rejected for epilepsy
surgery would like to benefit from novel techniques.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Over the past decades epilepsy surgery has become
an important treatment option for medically refrac-
tory epilepsy.1 However, up to 30% of referred
patients who undergo pre-surgical evaluation ulti-
mately are not considered eligible for epilepsy sur-
gery. Lack of clear focus localization is the main* Corresponding author at: Department of Clinical Neurophy-
siology, F02.201, University Medical Centre Utrecht, PO Box
85500, 3508 GA Utrecht, The Netherlands.
Tel.: +31 302507959; fax: +31 302505494.
E-mail address:G.J.M.Zijlmans@umcutrecht.nl (M. Zijlmans).
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doi:10.1016/j.seizure.2007.10.006reason for not offering surgery.2 As the diagnostic
arsenal and treatment possibilities expand, the
perspectives for refractory epilepsy patient change.
Recent developments in anatomical and func-
tional neuroimaging and epileptic source localiza-
tion may lead to improved focus localization, which
may offer new surgical vistas. Minor structural
abnormalities may not be visible with conventional
low field-strength MRI can underlie epileptogenic
areas. Higher resolution MRI or co-registration of
functional (MEG, EEG, PET and SPECT) source loca-
lization with anatomical MRI may improve detection
in these cases. In a recent study, in 65% of patients
with prior normal 1.5 T MRI, 3 T phased array MRI. Published by Elsevier Ltd. All rights reserved.
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weighted (DWI) and diffusion tensor imaging (DTI)
can detect white-matter-changes when conven-
tional MRI findings are normal.4,5 EEG-correlated
functional MRI yields blood-oxygen-level-dependent
(BOLD) activation following epileptiform EEG-dis-
charges that can be linked to the epileptic focus,
even in patients without MRI abnormalities.6 MR
techniques like magnetic resonance spectroscopy
(MRS) and methods that attempt to image neuronal
electrical currents like the Lorentz effect imaging
technique (LEI) are of experimental interest and
might become clinically relevant in the future.7
Typically, new diagnostic possibilities are tested in
newly referred patients. Some patients who have
been rejected for surgery might also benefit. One
can imagine, however, that the disappointment of
earlier rejection has led to acceptance of the situa-
tion and that these patients are reluctant to re-enter
into another uncertain period. Disease burden may
have decreased, either spontaneously or due to new
treatment options like vagal nerve stimulation (VNS)
and the advent of several new anti-epileptic drugs.8
We wondered if patients who were once rejected are
stillmotivated to undergo newdiagnostic procedures
which might re-open prospects of curative surgery.Patients and methods
Patients were selected from the national database
of the Dutch collaborative epilepsy surgery program
(DCESP), which registers all patients considered for
epilepsy surgery in the Netherlands since 1973. The
selection was based on the following criteria: (1)
rejection for epilepsy surgery between January 2001
and February 2006; (2) age older than 16 years; (3)
IQ > 80; (4) no major psychiatric problems; (5)
competent to fill in a Dutch questionnaire. Patients
were approached by telephone, and were subse-
quently sent self-completion questionnaires. For
respondents there was a chance of being offered
new MR-related diagnostic procedures that recently
became available in the Netherlands (3 T MRI and
EEG—fMRI). Non-responders were re-contacted by
phone and by sending another questionnaire to
achieve maximum response. Missing data were
derived from medical charts after written consent.
Data were analyzed using the SPSSv12.0 statistical
package (SPSS Inc., Chicago, USA).
Demographic and clinical characteristics
Data on current age, gender, marital status, employ-
ment, duration after rejection, age of disease onset
and treatment were obtained. Age, sex and timesince rejection of responders were compared to
non-responders. Data were compared to Dutch epi-
lepsy patients using one-sample t-tests for compar-
ison of means and binomial tests for binomial data.
Seizure frequency was estimated by the number of
seizures per month, during the preceding month and
during the past 2 years, and noting the time of the
last seizure and the longest seizure-free period
during the past 2 years. Frequencies were categor-
ized as at least once a month, less often than once a
month and not at all in the past year.
Motivation to undergo new diagnostic tests
The first question asked was whether the patient
would be motivated to undergo novel diagnostic
studies if these could possibly lead to reconsidera-
tion of surgery. This question was asked indepen-
dently for the reason of rejection. Influence of time
since rejection (independent sample t-test) and
reason for rejection (x2-test) on motivation was
studied.
Quality of life
Patients completed the SF-36: a non-disease-speci-
fic health status measure accessing eight different
domains for which data on epilepsy patients and
general population in the Netherlands are avail-
able.9,10 The scores of the general population, but
not of the epilepsy population, were age-matched
to the study-population. Scores of the rejected
patients were compared to Dutch epilepsy patients
using one-sample t-tests.Results
Between January 2001 and February 2006, 441
patients (>16 years) were evaluated for surgery
in the Netherlands by the DCESP. 37 patients were
still in the work-up process at the cut-off date and
39 patients had withdrawn during evaluation. Of
the 365 patients for whom a final decision was
reached, 89 had been rejected (24%; 95% confidence
interval 20—29%). Reasons for rejection were: no
clear focus localization (47 patients), multi-focality
(28 patients), seizures arising from a functionally
eloquent area (12 patients) and coagulation disor-
ders (2 patients). Of these 89, 18 patients were
excluded from the study because of low IQ, psychia-
tric or language problems. Of the remaining 71
included patients, 64 (90%) completed question-
naires. Most of the non-responders agreed to fill
in the questionnaires, but did not. 2 non-responders
refused to participate after the first call. Charac-
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Table 1 Demographic and clinical characteristics of respondents, non-respondents and a norm population of Dutch
patients with epilepsy (9)
Responders
(N = 64)
Non-responders
(N = 7)
Dutch epilepsy
patients (N = 747)
Mean age (years), p = 0.03 37 38 41
Duration after rejection (years) 2.7 2.4
% female 44 43 54
% married/cohabiting, p = 0.02 (one-tailed) 54.7 68
% in paid employment, p = 0.42 53 51
Mean age at onset (years), p < 0.001 13 21
Mean duration (years), p < 0.001 24 17
Seizure frequency
Mean 24/month (range: 0—363)
None (%) 1.6 38
<1/month (%) 12.5 25
At least once a month (%) 85.9 37
From which daily (%) 18.8
% on >1 anti-epileptic drug, p < 0.001 98 46
Data of responders are compared to Dutch epilepsy patients.teristics of responders, non-responders and Dutch
epilepsy patients are presented in Table 1.
Motivation for new diagnostics
The motivation to undergo new diagnostic proce-
dures is presented in Table 2. The motivation was
not influenced by the reason for rejection (Fisher’s
exact test two-sided p = 0.56) or the time after
rejection ( p = 0.95). Of the highly motivated
patients, localization problems (no clear focus or
multi-focality) had been the main reason for rejec-
tion of surgery in 45 patients (70% of all patients). Of
these, 9 patients had had a VNS implanted, which is
a contra-indication for MRI. This means that for 36
out of 64 patients (56%; CI 43—69%) favorable con-
ditions were met for re-evaluation by new MRI-
techniques.
Disease burden
Four patients (6%) did not have seizures during
the last 6 months. Neither recent treatment (new
medication or VNS) nor a demographic or diseaseTable 2 Motivation to undergo new diagnostic proce-
dures
Motivation Responders
(N = 64)
95% CI in %
High 56 77—94
Low 8 6—23
Unknown 1
Not needed
(seizure frequency #)
4 2—15characteristic could explain this improvement
(two-tailed t-tests). Fig. 1 shows scores on eight
SF-36-domains.Discussion
Patients rejected as surgical candidates form a
specific subgroup of patients with epilepsy. Com-
pared to other patients with epilepsy, low scores on
the vitality and social domains of quality of lifewere
observed. Surprisingly, equal employment ratios
and better scores on bodily pain and physical func-
tioning were found. As the data of Dutch epilepsy
patients were not corrected for age the actual
difference on vitality and social domains, but also
emotional and physical role limitations, may be
even greater.
Most rejected patients are highly motivated to
undergo novel diagnostic procedures that open pro-
spects of surgery again. As the question was whether
they were motivated for the diagnostic procedures
in the first place and filling out the questionnaire
could lead to novel MR diagnostics, the actual num-
ber of patients that are motivated for surgery might
be lower. MRI techniques will not always be applic-
able, for instance because of VNS. Also, a selection
should be made regarding which patients might
profit from which techniques, based on the reason
for rejection.
Few patients rejected for epilepsy surgery would
no longer need surgery because of a low seizure
frequency. A comparable number was found by
others,1 who reported that in a group of patients
referred for epilepsy surgery 3% became seizure free
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Figure 1 Mean scale scores on the domains of the SF-36 for the study population compared with a group of Dutch
patients with epilepsy and the general Dutch population. A higher score means a better score (so less pain, better
functioning, etc.) on all domains. Significant differences between the study population and the Dutch patients with
epilepsy are marked with an * ( p < 0.05; two-tailed one-sample t-test).after conservative treatment for 1 year. Apparently,
even in long-standing refractory epilepsy sponta-
neous improvement is possible, at least within the
scope of 1 year.
It is likely that the motivation to undergo new
procedures is not restricted to Dutch patients. In
the Netherlands, most tests used worldwide are
available like MRI (including high-resolution 3D
T1 and FLAIR images), video-EEG, MEG, PET, ictal
and interictal SPECT and invasive electrocortico-
graphy. The percentage of rejected patients is
comparable with an American study.2 Moreover,
neither the reason of rejection for epilepsy surgery,
nor the time lapse after rejection had an effect on
the motivation of patients to undergo renewed
evaluation.
Neurologists screening patients for epilepsy sur-
gery should keep track of rejected patients and
offer them new diagnostic techniques when these
become available. Re-evaluation should be part of
epilepsy surgery programs worldwide.Acknowledgments
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